logo

Health Care News

Share

Biogen Says FDA Accepts For Review The Abbreviated BLA For BIIB800

Syncona: Autolus Announces FELIX Trial Of Obe-cel Meets Its Primary Endpoint

Bioxytran Gets Approval To Optimize Dosage In COVID-19 Patients

Akero Therapeutics: Efruxifermin Gets Breakthrough Therapy Designation From FDA For The Treatment Of NASH

Roche: Elecsys AD CSF Abeta42 And PTau181 Assays Get FDA Clearance

Novartis Says Phase III APPOINT-PNH Study Of Oral Monotherapy Iptacopan Meets Primary Endpoint